eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Draft Guidances for Industry and Review Staff: Pediatric Information Incorporated Into Human Prescription Drug and Biological Products Labeling

Draft Guidances for Industry and Review Staff: Pediatric Information Incorporated Into Human Prescription Drug and Biological Products Labeling

Document ID: FDA-2013-D-0169-0001
Document Type: Notice
Agency: Food And Drug Administration
Topics: No Topics associated with this document
Federal Register Number: 2013-04625
View Document:  View as format pdf View as format html

Details Information

Document Subtype: Notice of Availability
Received Date: February 28 2013, at 12:00 AM Eastern Standard Time
Start-End Page: 13686 - 13687
Page Count: 2
Comment Start Date: February 28 2013, at 12:00 AM Eastern Standard Time
Comment Due Date: April 29 2013, at 11:59 PM Eastern Standard Time

Comments

    View All
Total: 9
Gilead Sciences Inc - Comment
Posted: 05/21/2013     ID: FDA-2013-D-0169-0007

Apr 29,2013 11:59 PM ET
Sanofi - Comment
Posted: 05/21/2013     ID: FDA-2013-D-0169-0006

Apr 29,2013 11:59 PM ET
The Pharmaceutical Research and Manufacturers of America (PhRMA) - Comment
Posted: 05/21/2013     ID: FDA-2013-D-0169-0008

Apr 29,2013 11:59 PM ET
Roche Genentech - Comment
Posted: 05/21/2013     ID: FDA-2013-D-0169-0011

Apr 29,2013 11:59 PM ET
Novo Nordisk Inc. - Comment
Posted: 05/21/2013     ID: FDA-2013-D-0169-0003

Apr 29,2013 11:59 PM ET

Related Documents

Total: 0
No documents available.